Home / Inspections / 1304182

FDA Inspection 1304182 — Reproductive Medicine Associates Of Philadelphia, P.c.

Reproductive Medicine Associates Of Philadelphia, P.c. — FEI 3007936041

The FDA completed an inspection of Reproductive Medicine Associates Of Philadelphia, P.c. on February 5, 2026 in Langhorne, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 5, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Langhorne, PA (United States)

Facility

Other inspections at this facility

  • 1196232 (NAI Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1086144 (NAI Fri Mar 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008967 (NAI Thu Apr 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 912803 (NAI Thu Feb 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 816543 (NAI Thu Jan 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources